Cargando…
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China
Multiple myeloma (MM) is a heterogeneous disease that remains incurable with significant interpatient variability in outcomes. Regulatory B cells (Bregs) were observed to be involved into specific defects in MM. Here, we provide our risk-adapted approach to newly diagnosed MM (NDMM), combining with...
Autores principales: | Zou, Zhongqing, Guo, Tingting, Cui, Jian, Tang, Wenjiao, Li, Yan, Wang, Fangfang, Dong, Tian, Yang, Yunfan, Feng, Yan, Ho, Matthew, Zhang, Li, Pan, Ling, Niu, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040702/ https://www.ncbi.nlm.nih.gov/pubmed/33854623 http://dx.doi.org/10.7150/jca.53209 |
Ejemplares similares
-
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum
por: Zou, Zhongqing, et al.
Publicado: (2022) -
A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma
por: Tang, Wenjiao, et al.
Publicado: (2022) -
Predictive Values of PET/CT in Combination With Regulatory B Cells for Therapeutic Response and Survival in Contemporary Patients With Newly Diagnosed Multiple Myeloma
por: Cui, Jian, et al.
Publicado: (2021) -
Prognostic significance of CD56 antigen in newly diagnosed multiple myeloma: A real-world retrospective study
por: Li, Liping, et al.
Publicado: (2022) -
Regulatory Effect and Mechanism of Erythroblastic Island Macrophages on Anemia in Patients with Newly Diagnosed Multiple Myeloma
por: Huang, Hao, et al.
Publicado: (2023)